Durvalumab as Consolidation for Patients LS-SCLC

Clinical trial NCT07055581 · RECRUITING

Trial details

NCT number: NCT07055581
Sponsor: Qian Chu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Limited Stage

Start date: 2026-02-24
Primary completion: 2029-07-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.